Q4 2025 Stevanato Group SpA Earnings Call Transcript
Key Points
- Stevanato Group SpA (STVN) reported a 9% increase in total company revenue at constant currency rates for fiscal 2025, demonstrating strong execution of strategic priorities.
- The Biopharmaceutical and Diagnostic Solutions (BDS) segment achieved double-digit top-line growth, driven by a 29% increase in high-value solutions, which accounted for 46% of total company revenue.
- Gross profit margin improved by 160 basis points compared to 2024, primarily due to the strong performance in high-value solutions.
- The company successfully expanded its capacity for high-value syringes in Fishers, Indiana, and Latina, Italy, to meet growing demand.
- Stevanato Group SpA (STVN) anticipates continued growth in the GLP-1 market, which accounted for approximately 19-20% of total company revenue in 2025, with expectations of mid-teens growth in 2026.
- The engineering segment experienced a 23% revenue decline in the fourth quarter of 2025, with expectations of further revenue decrease in 2026 due to lower order intake.
- Foreign currency translation posed a headwind throughout fiscal 2025, impacting revenue growth negatively.
- The company faces challenges in converting opportunities into new firm orders within the engineering segment, with a slower-than-anticipated sales cycle.
- Tariffs and unfavorable foreign currency effects partially offset the improvements in gross profit margin.
- Stevanato Group SpA (STVN) is pivoting away from certain non-high-value product categories, which may impact revenue from those segments.
Chlo.
The to.
Good afternoon. This is the Corusco conference operator. Welcome and thank you for joining the Stefanato Group 4th quarter and full year 2025 financial results conference call.
As a reminder, all participants are in listen-only mode, and after the presentation there will be an opportunity to ask questions.
Should anyone need assistance during the conference call, they may signal an operator by pressing 0 on their telephone.
At this time, I would like to turn the conference over to Ms. Lisa Miles, Chief Communications Officer. Please go ahead, madam.
Good morning and thank you for joining us. With me today is Franco Stevenato, Chairman and Chief Executive Officer, and Marco de Lago, Chief Financial Officer.
You can find a presentation to accompany today's results on the investor relations page of our website, which can be located under the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
